…Introduction Eosinophilic oesophagitis is a chronic, immune mediated inflammatory disorder of the oeso…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 8 of 2459…from 5.59 million in 1990 to 6.31 million in 2019. 1 Late onset neonatal sepsis is an infection occurring in newborns after 72 hours of life, t…
…ptions, and diabetes-induced retinal complications.Introduction Diabetes prevalence is rising globally, impacting around 537 million ind…
…he results of the ongoing SEPRA trial, we found that injectable semaglutide was superior to SoC with 30% more patients achieving A1C <7% at…
… 25.70% showed a significantly strong positive association with T2D risk. The results of the sensitivity analysis were generally co…
…ration rate. 22 The study included adults (n=1229) with stage 3 chronic kidney disease (estimated glomerular filtration rate 30-59 mL/min/1.73 m2 incl…
…rolled in a first-line phase II trial of the anti-PD-1 antibody nivolumab.13 Together, these data suggest then an immunologically enriche…
…-phase development to practice-changing trials, particularly in prostate cancer and neuroendocrine tumours. 51 In prostate cancer, the phase II…
… (C60–C63) at 38.8% (n=650), which almost entirely consisted of prostate cancer (38.0%; n=637), and malignant neoplasms of digestive organs at …
…ysiological environment of pregnancy and delivery. Opioids like fentanyl and sufentanil have proven to be reliable for providing quick p…
…omes and 37% of its improvement in CV outcomes were mediated by finerenone’s effect on decreasing UACR.28 While achieving reduction in UAC…